Dermata Therapeutics Inc (DRMA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.25
• Market Cap: $3.90M
• P/E Ratio: 0.08
• EPS: $15.24
• 52-Week High: $14.60
• 52-Week Low: $1.16

Market Sentiment

Dermata Therapeutics Inc currently has a Bearish sentiment score of -0.20.

About Dermata Therapeutics Inc

None

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Dermata Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does DRMA pay dividends?

Dermata Therapeutics Inc (DRMA) does not currently pay a regular dividend.

What is DRMA's P/E ratio?

Dermata Therapeutics Inc has a price-to-earnings (P/E) ratio of 0.08.

What is DRMA's market cap?

Dermata Therapeutics Inc (DRMA) has a market capitalization of $3.90M with a current stock price of $1.25.